Revitaderm Wound Care Benzalkonium Chloride OTC Drug Recall
Blaine Labs Inc is recalling Revitaderm Wound Care (Benzalkonium Chloride 0.1%) topical antiseptic gel due to current good manufacturing practice (CGMP) deviations. The product was manufactured in the same facility under the same conditions as a product found to be contaminated.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving CGMP deviations at the manufacturing facility where a contamination event occurred. No specific illnesses, injuries, or confirmed contamination of the recalled product itself are reported in the source text, making it a precautionary recall based on manufacturing conditions rather than confirmed product defect.
Plain-English summary
Blaine Labs Inc is recalling Revitaderm Wound Care, a first aid antiseptic gel containing benzalkonium chloride 0.1%, distributed nationwide in the United States. The recall affects approximately 5,555 bottles and tubes.
The recall was issued due to current good manufacturing practice (CGMP) deviations. Specifically, the recalled product was manufactured in the same facility under the same conditions as another product that was found to be contaminated.
The recalled product is available in two package sizes: 1.0 fluid ounce (16 mL) bottles with long pointy caps (NDC 63347-120-02) and 3.0 fluid ounce (85 g) tubes with short twist caps (NDC 63347-120-01). Affected lot numbers include BL3435 (expiration 11/06/26) and BL3525 (expiration 08/07/27) for both package sizes.
Consumers who have purchased this product should stop using it immediately and contact Blaine Labs Inc or their healthcare provider if they have any health concerns.
The recalled product
- Product
- REVITADERM WOUND CARE (BENZALKONIUM CHLORIDE)
- Brand
- REVITADERM WOUND CARE
- Manufacturer
- Blaine Labs Inc
- Affected units
- 5,555
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lots: (a) 1 oz - BL3435
- Exp 11/06/26
- BL3525
- Exp 08/07/27. (b) 3 oz- Lots # BL3435
- 11/06/26 & BL3525
- 08/07/27
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 8 recalled by Blaine Labs Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same brand · REVITADERM WOUND CARE
- SevereBlaine Labs Revitaderm Wound Care Gel Recalled for Bacillus Contamination
FDA (Drugs) · 2022-03-30
Same manufacturer · Blaine Labs Inc
See all →- SevereRevitaderm Wound Care Gel recalled for microbial contamination
FDA (Drugs) · 2026-07-08
- ModerateTerpenicol Antifungal Solution Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-08
- Moderatevite20 Antifungal Cream recalled due to stability testing deviations
FDA (Drugs) · 2026-07-08
- ModerateTERPENICOL Antifungal Cream Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFungal Fusion antifungal kit recalled for discontinued stability testing
FDA (Drugs) · 2026-07-08
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- SevereShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19